Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription 06.05.2024 1 Anal Biochem 1 Ann Med Surg (Lond) 4 Anticancer Res 1 Arthritis Care Res (Hoboken) 5 Asian Pac J Cancer Prev 1 Biomedicines 1 BMC Cancer 2 BMC Womens Health 1 Cancer Cytopathol 1 Cancers (Basel) 1 Cell Death Discov 1 Cell Signal 1 Clin Cancer Res 1 Clin Exp Pharmacol Physiol 1 Crit Rev Oncol Hematol 3 Cureus 1 EClinicalMedicine 1 Eur J Obstet Gynecol Reprod Biol 1 Fertil Steril 1 Glob Health Sci Pract 1 Health Policy 1 Heliyon 2 Int J Cancer 1 Int J Gynecol Cancer 1 Int J Public Health 1 Iran J Public Health 1 J Gynecol Oncol 1 J Low Genit Tract Dis 1 J Obstet Gynaecol Res 1 J Transl Med 1 JNCI Cancer Spectr 1 Lancet Reg Health Southeast Asia 2 Life (Basel) 1 Medicina (B Aires) 1 Medicina (Kaunas) 1 Nat Commun 1 New Microbiol 1 Oncol Rep 1 Oncologist 1 Pan Afr Med J 1 Photodiagnosis Photodyn Ther 1 Prz Menopauzalny 1 Reprod Sci 1 Viruses

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anal Biochem

1. WANG H, Wang D, Xu Y
   Exonuclease-iii -propelled DNAzyme cascade for sensitive and reliable cervical cancer related miRNA analysis.
   Anal Biochem. 2024;691:115547.
   PubMed         Abstract available
   
   

   
   Ann Med Surg (Lond)

2. SHRATEH ON, Habib A, Jalamneh B, Omar BMM, et al
   The level of medical students' knowledge regarding the prevention of cervical cancer.
   Ann Med Surg (Lond). 2024;86:2591-2597.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. KUM SJ, Jung YY, Kim HS
   Comparison of Clinicopathological and Prognostic Characteristics Between Minimal Deviation Adenocarcinoma and Gastric-type Endocervical Adenocarcinoma.
   Anticancer Res. 2024;44:2193-2204.
   PubMed         Abstract available
   
   
4. WILLSON CM, Lequio M, Zhu Z, Wakefield MR, et al
   The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells.
   Anticancer Res. 2024;44:1807-1815.
   PubMed         Abstract available
   
   
5. JUNG BC, Woo SH, Kim SH, Kim YS, et al
   Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells.
   Anticancer Res. 2024;44:1853-1862.
   PubMed         Abstract available
   
   
6. YAMAOKA Y, Tamura S, Yamanoi K, Taki M, et al
   Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
   Anticancer Res. 2024;44:2009-2019.
   PubMed         Abstract available
   
   

   
   Arthritis Care Res (Hoboken)

7. BRUERA S, Bowman S, Huang Y, Suarez-Almazor ME, et al
   Factors associated with adherence of cervical cancer screening in women with Systemic Lupus Erythematosus.
   Arthritis Care Res (Hoboken). 2024 Apr 29. doi: 10.1002/acr.25355.
   PubMed         Abstract available
   
   

   
   Asian Pac J Cancer Prev

8. MARZBANRAD Z, Karimi-Zarchi M, Noei-Teymoordash S, Motamedinasab M, et al
   A Comprehensive Integration of Data Regarding the Correlation of TNF-alpha rs1800629 Polymorphism with Susceptibility to Cervical Cancer.
   Asian Pac J Cancer Prev. 2024;25:1155-1167.
   PubMed         Abstract available
   
   
9. CHAOPOTONG P, Laiwejpithya S, Areeswate C
   Prevalence of High-Risk HPV Detection and HPV Vaccination in Cervical Cancer Screening During the HPV Vaccination Era at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.
   Asian Pac J Cancer Prev. 2024;25:1241-1245.
   PubMed         Abstract available
   
   
10. DEWI SM, Bennett LR, Barrett A
    Exploring Indonesian Primary Schoolgirls' Experiences of School-based HPV Vaccination, Knowledge of HPV Risks and Prevention, and Preferences for Cervical Cancer Education.
    Asian Pac J Cancer Prev. 2024;25:1285-1292.
    PubMed         Abstract available
    
    
11. ALIM S, Siddiqui SA, Akram M, Hakim S, et al
    A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A T
    Asian Pac J Cancer Prev. 2024;25:1333-1338.
    PubMed         Abstract available
    
    
12. SHEASHEA AA, Ahmed FA, El Zayat E, Ebeed BW, et al
    In Vitro Antiviral and Anticancer Effects of Tanacetum sinaicum Essential Oil on Human Cervical and Breast Cancer.
    Asian Pac J Cancer Prev. 2024;25:1457-1471.
    PubMed         Abstract available
    
    

    
    Biomedicines

13. NIU J, Chen Y, Chai HC, Sasidharan S, et al
    Exploring MiR-484 Regulation by Polyalthia longifolia: A Promising Biomarker and Therapeutic Target in Cervical Cancer through Integrated Bioinformatics and an In Vitro Analysis.
    Biomedicines. 2024;12:909.
    PubMed         Abstract available
    
    

    
    BMC Cancer

14. ZHOU Y, Wang W, Tang J, Hu K, et al
    Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    BMC Cancer. 2024;24:548.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

15. KIRABIRA J, Kayondo M, Bawakanya SM, Nsubuga EJ, et al
    Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    BMC Womens Health. 2024;24:266.
    PubMed         Abstract available
    
    
16. TAKAC I, Kavalar R, Lovrec MR, Lovrec VG, et al
    Concomitant ectopic Enterobius vermicularis infection in uterine cervical cancer.
    BMC Womens Health. 2024;24:265.
    PubMed         Abstract available
    
    

    
    Cancer Cytopathol

17. BOGANI G, Sopracordevole F, Ciavattini A, Vizza E, et al
    HPV persistence after cervical surgical excision of high-grade cervical lesions.
    Cancer Cytopathol. 2024;132:268-269.
    PubMed        
    
    

    
    Cancers (Basel)

18. STANIEWSKA E, Grudzien K, Stankiewicz M, Raczek-Zwierzycka K, et al
    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy.
    Cancers (Basel). 2024;16:1542.
    PubMed         Abstract available
    
    

    
    Cell Death Discov

19. LIU H, Liu Y, Zhou Y, Chen X, et al
    TM7SF2-induced lipid reprogramming promotes cell proliferation and migration via CPT1A/Wnt/beta-Catenin axis in cervical cancer cells.
    Cell Death Discov. 2024;10:207.
    PubMed         Abstract available
    
    

    
    Cell Signal

20. CHEN W, Xie X, Liu C, Liao J, et al
    IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
    Cell Signal. 2024;119:111192.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

21. SHETH SS, Oh JE, Bellone S, Siegel ER, et al
    Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
    Clin Cancer Res. 2024;30:1768-1777.
    PubMed         Abstract available
    
    

    
    Clin Exp Pharmacol Physiol

22. TIAN Q, Huang J, Zhang Q, Zhao J, et al
    N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Clin Exp Pharmacol Physiol. 2024;51:e13864.
    PubMed         Abstract available
    
    

    
    Crit Rev Oncol Hematol

23. JANJUA D, Thakur K, Aggarwal N, Chaudhary A, et al
    Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
    Crit Rev Oncol Hematol. 2024;197:104346.
    PubMed         Abstract available
    
    

    
    Cureus

24. ALREFAI EA, Alhejaili RT, Haddad SA
    Human Papillomavirus and Its Association With Cervical Cancer: A Review.
    Cureus. 2024;16:e57432.
    PubMed         Abstract available
    
    
25. ZHANG R, Xu W, Yang S, Hu D, et al
    Correction: Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
    Cureus. 2024;16:c171.
    PubMed         Abstract available
    
    
26. BALAN L, Cimpean AM, Secosan C, Sorop VB, et al
    Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters.
    Cureus. 2024;16:e59077.
    PubMed         Abstract available
    
    

    
    EClinicalMedicine

27. ABBAS K, Yoo KJ, Prem K, Jit M, et al
    Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.
    EClinicalMedicine. 2024;70:102524.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

28. WANG D, Fang X
    Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:202-208.
    PubMed         Abstract available
    
    

    
    Fertil Steril

29. HUR CE, Goldberg JM
    Laparoscopic transfundal approach to cervical dilation: a novel treatment for cervical stenosis and cervical factor infertility.
    Fertil Steril. 2024;121:890-891.
    PubMed         Abstract available
    
    

    
    Glob Health Sci Pract

30. CHIZYUKA NA, Crawford E, Hebert KS, Gaju S, et al
    Lessons From the Design and Rollout of an Electronic Medical Record System for Cervical Cancer Screening in Rwanda.
    Glob Health Sci Pract. 2024 Apr 26. doi: 10.9745/GHSP-D-23-00469.
    PubMed         Abstract available
    
    

    
    Health Policy

31. RIGBY S, Greenley R, Uuskula A, Tisler A, et al
    Expanding eligibility and improving quality of cervical cancer screening in Estonia: The 2021 reforms.
    Health Policy. 2024;144:105077.
    PubMed         Abstract available
    
    

    
    Heliyon

32. MUKSIMOVA S, Umirzakova S, Kang S, Cho YI, et al
    CerviLearnNet: Advancing cervical cancer diagnosis with reinforcement learning-enhanced convolutional networks.
    Heliyon. 2024;10:e29913.
    PubMed         Abstract available
    
    

    
    Int J Cancer

33. GILHAM C, Nedjai B, Scibior-Bentkowska D, Reuter C, et al
    Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Int J Cancer. 2024;155:81-92.
    PubMed         Abstract available
    
    
34. LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al
    The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

35. SHI V, Grover S, Huang Y, Thaker PH, et al
    Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Int J Gynecol Cancer. 2024 Apr 29:ijgc-2024-005303.
    PubMed         Abstract available
    
    

    
    Int J Public Health

36. LEFEUVRE C, De Pauw H, Le Duc Banaszuk AS, Pivert A, et al
    Corrigendum: Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.
    Int J Public Health. 2024;69:1607299.
    PubMed         Abstract available
    
    

    
    Iran J Public Health

37. VUKOMANOVIC IS, Kocic S, Vukomanovic V, Janicijevic K, et al
    Assessment of Sexual Health and Use of Cervical Cancer Screening among the Female Working Population.
    Iran J Public Health. 2024;53:198-207.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

38. YIN X, Liu X, Gong H, Chu Z, et al
    LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling.
    J Gynecol Oncol. 2024 Apr 19. doi: 10.3802/jgo.2024.
    PubMed         Abstract available
    
    

    
    J Low Genit Tract Dis

39. KHURANA S, Smolar I, Warren L, Velasquez J, et al
    Time Differences From Abnormal Cervical Cancer Screening to Colposcopy Between Insurance Statuses.
    J Low Genit Tract Dis. 2024 May 2. doi: 10.1097/LGT.0000000000000812.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

40. LIU S, Gu Y, Shi Y, Yu S, et al
    AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion.
    J Obstet Gynaecol Res. 2024 Apr 29. doi: 10.1111/jog.15959.
    PubMed         Abstract available
    
    

    
    J Transl Med

41. ZHANG W, Yin Y, Jiang Y, Yang Y, et al
    Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
    J Transl Med. 2024;22:396.
    PubMed         Abstract available
    
    

    
    JNCI Cancer Spectr

42. KINSLOW CJ, DeStephano DM, Neugut AI, Taparra K, et al
    Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    JNCI Cancer Spectr. 2024;8:pkae022.
    PubMed         Abstract available
    
    

    
    Lancet Reg Health Southeast Asia

43. SHANKAR A, Sehra D, Roy S
    Cervical cancer advocacy: needs more than faking death.
    Lancet Reg Health Southeast Asia. 2024;25:100411.
    PubMed        
    
    

    
    Life (Basel)

44. CHOI Y, Lee D, Kim NY, Seo I, et al
    Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances.
    Life (Basel). 2024;14:443.
    PubMed         Abstract available
    
    
45. LEE SM, Seol A, Cho HW, Min KJ, et al
    Optimal Dietary Intake of Riboflavin Associated with Lower Risk of Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010-2021.
    Life (Basel). 2024;14:529.
    PubMed         Abstract available
    
    

    
    Medicina (B Aires)

46. ARROSSI S, Binder F, Ituarte C, Martiarena N, et al
    [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Medicina (B Aires). 2024;84:236-248.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

47. D'AMATO A, Riemma G, Agrifoglio V, Chiantera V, et al
    Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 cm Undergoing Fertility-Sparing Treatment: A Systematic Review.
    Medicina (Kaunas). 2024;60:608.
    PubMed         Abstract available
    
    

    
    Nat Commun

48. ARROYO MUHR LS, Gini A, Yilmaz E, Hassan SS, et al
    Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer.
    Nat Commun. 2024;15:3679.
    PubMed         Abstract available
    
    

    
    New Microbiol

49. YAMAN M, Ozcan HEA, Bakir A
    High-Risk Human Papilloma Virus Genotype Distribution and Correlation with Cervical Cytomorphological Data in Turkish and Immigrant Women in Mersin Province.
    New Microbiol. 2024;47:88-97.
    PubMed         Abstract available
    
    

    
    Oncol Rep

50. LI W, Liang J, Zhang Z, Lou H, et al
    [Retracted] MicroRNA?329?3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2024;51:86.
    PubMed         Abstract available
    
    

    
    Oncologist

51. STROETMANN CY, Gizaw M, Alemayehu R, Wondimagegnehu A, et al
    Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia.
    Oncologist. 2024;29:e655-e664.
    PubMed         Abstract available
    
    

    
    Pan Afr Med J

52. NGWIBETE A, Ogunbode O, Swende LT, Agbada MM, et al
    Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
    Pan Afr Med J. 2024;47:50.
    PubMed         Abstract available
    
    

    
    Photodiagnosis Photodyn Ther

53. WANG J, Liu S, Wei B, Liu Y, et al
    Frequency shift Raman-based sensing of serum MicroRNA for ultrasensitive cervical cancer diagnosis.
    Photodiagnosis Photodyn Ther. 2024;46:104105.
    PubMed         Abstract available
    
    

    
    Prz Menopauzalny

54. TSONEVA E, Dimitrova P, Metodiev M, Shivarov V, et al
    Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer.
    Prz Menopauzalny. 2024;23:6-13.
    PubMed         Abstract available
    
    

    
    Reprod Sci

55. XUE X, Pan Y, Li C
    Circ_TMCO3 Inhibits the Progression of Cervical Cancer by Activating FRMD6 Expression by Restraining miR-1291.
    Reprod Sci. 2024 May 3. doi: 10.1007/s43032-024-01549.
    PubMed         Abstract available
    
    

    
    Viruses

56. PESUT E, Simic I, Fures R, Milutin Gasperov N, et al
    Monitoring HPV Prevalence and Risk Cofactors for Abnormal Cytology in the Post-Vaccination Period among Croatian Women.
    Viruses. 2024;16:642.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.